BridgeMD
Prevenir el dolor en las primeras 24-48h después de una cirugía de la mama. Se aplica inyectando con jeringa a nivel local, un anestésico llamado lidocaína en la zona de la cicatriz quirúrgica
EU CTIS ID: 2025-521162-10-00
What this study is testing
Demostrar que la infiltración intraoperatoria de lidocaína al 0.5% en la incisión quirúrgica, disminuye la incidencia de dolor agudo postoperatorio 2. Demostrar que la infiltración intraoperatoria de lidocaína al 0.5% disminuye los requerimientos de analgesia postoperatoria, especialmente de opiáceos
- Therapeutic use (Phase IV)
A plain-language read of the study's public EU CTIS listing. The study team confirms the details.
Who can take part
You may be able to join if
- Mujer mayor de 18 años, diagnosticada de neoplasia maligna de mama, candidata a tratamiento quirúrgico programado en nuestro centro, Consorci Sanitari Integral, y que hayan firmado el consentimiento informado
You likely can't join if
- -Alergia al anestésico local lidocaína -Antecedente de cirugía mamaria, torácica o de extremidad superior -Cirugía de recidiva del cáncer de mama -Dolor preoperatorio de la zona a intervenir -Alteración neurológica previa de la pared torácica -Antecedente de accidente cerebrovascular con afectación de la extremidad superior ipsilateral a la cirugía -Dificultad idiomática
The study team makes the final eligibility decision.
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling female, 65+ years, 18-64 years. The study team makes the final eligibility decision.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from EU CTIS; the study team decides eligibility.